Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	May 01, 2019
Interest Rate Swap Lock Agreement [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Loss on Settlement of Agreements	$ 4.2
Years Amortized Into Interest Expense	10 years
Flawless Acquisition
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities		$ 0.0		$ 182.0
Flawless Acquisition | Updated Sales Forecasts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Increase (decrease) in estimate of contingent consideration liability		(98.0)	$ (94.0)
Thera Breath Acquisition
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities	$ 14.0	14.0
Thera Breath Acquisition | Maximum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Payable Period	4 years
Thera Breath Acquisition | Minimum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Payable Period	2 years
Zicam Acquisition
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities	$ 20.0	$ 20.0
Business Acquisition Payable Period	5 years